Our funding is concordant with the previous IL-17R knockout mice study that IL-17 signaling plays a critical role in the development of TNBS-induced colitis and may represent a target for therapeutic intervention for IBD (Zhang et al., 2006). The gene discussed is IL17A; the disease is colitis.